Lancashire and South Cumbria Formulary Home Admin netFormulary Chapters Medicines A-Z News Mobile Reports Feedback  Search  Document Library All Pathways and Guidance | Change log | High Cost Drugs | LSC Critical Care Medicines Information | LSC ICS proxy ordering of medications in care homes | LSC Respiratory Resources | LSCMMG Consultations | LSCMMG Endorsed Secondary Care Guidelines | LSCMMG Minutes | LSCMMG Workplans | LSCMMG: About | New Medicine Reviews | PGDs | Place documents | Shared Care Guidelines | All Pathways and Guidance   Antihistamine: Position Statement  Antipsychotics: second generation long-acting injection (LAI) antipsychotics  Asthma Treatment Guidelines for Adults (Aged 12 and over)  Asthma Treatment Guidelines for Children  Atrial Fibrillation: Pathway for the prevention of stroke and systemic embolism in AF in the absence of valvular heart disease  Axial Spondyloarthritis: High Cost Drugs Commissioning Pathway  Bariatric surgery guidelines for prescribing of vitamins and nutritional supplements: Position Statement  Branded Generics: Position Statement  Camouflaging Products: Position Statement  Cannabis-Based Medicinal Products: Position Statement  Colistimethate for nebulisation: Prescribing Information Sheet  Constipation: Primary Care Pathways  COPD Desktop Guideline  Degarelix: Prescribing Information Sheet  Dementia: Management of Behavioural and Psychological Symptoms of Dementia - Primary Care Summary Document  Dementia: Management of Behavioural and Psychological Symptoms of Dementia in Primary and Secondary Care  Dementia: Prescribing Information Sheet  Denosumab: Position Statement  Diabetes - Choice of Safety Pen Needles and Lancets  Diabetes - Pen Needles/Lancets  Diabetes - Position Statement Safety Needles and Safety Lancets  Diabetes -GLP-1 Agreement form  Diabetes Guideline for antihyperglycaemic therapy in adults with type 2 diabetes  Diabetes: Appendix B antihyperglycaemics guideline - diabeties self management contract (Prescriber Resource)  Diabetes: Recommended meters, strips and devices  Dosulepin: Guidelines for Primary Care  E-Cigarettes: Position Statement  Erectile Dysfunction Guideline  Eye: LSC Community Urgent Eye Service (CUES)  Fentanyl patch application guidance for patients - adults only  Fluoride High Strength Toothpastes: Position Statement  Gender incongruence: NHSE guidance to primary care about unregulated providers who supply hormone medications to children and young people for gender incongruence  Generic Biosimilar Medicines: Position Statement  Gluten-Free food products: Position Statement  Good prescribing in primary care guidance document July 2025  Gout Prescribing Guidance  Headache Management Guideline For Adults  HidraWear: Position Statement  Hydroxychloroquine: Prescribing Information Sheet  Inclisiran for treating primary hypercholesterolaemia or mixed dyslipidaemia: Position Statement  Inflammatory Bowel Disease​: High Cost Drugs Commissioning Pathway  Insomnia in Adults  Insulin Toujeo: Information Sheet and Good Practice Guide  Ivabradine: Prescribing Information Sheet  Juvenile Idiopathic Arthritis in adult patients: Position statement for biological agents  Levetiracetam (Keppra®) prescribing: bioequivalence and antiepileptic drugs: Position Statement  Linezolid: Prescribing Information Sheet  Lipid Management: Pathway for Primary Prevention of Cardiovascular Disease (CVD)  Lipid Management: Pathway for Secondary Prevention of Cardiovascular Disease (CVD)  Low molecular weight heparin (LMWH) prescribing guide  Melatonin Pathway (Children)  Mesalazine: Prescribing Information Sheet  Morphine (High dose) prescribing for chronic non-cancer pain: Position Statement  Neuropathic Pain: Primary Care Management  Opioid reduction: best interests opioid reduction position statement  OpioId treatment: patient-prescriber opioid treatment agreement  Opthalmology Macular Pathways  Oral Nutritional Supplements in Primary Care  Osteoporosis: Secondary fracture prevention patient treatment pathway  Over The Counter (OTC) Items That Should Not Be Routinely Prescribed In Primary Care Policy  Overactive bladder in female adults  Pain: Assessing suitability for strong opioid use  Palliative Care Clinical Practice Summary See more information under chapter 21 'Palliative Care Formulary'.  PKU (Phlexy-Vit) Prescribing of multivitamins and phenylalanine-free amino acid substitutes for adults and children  Position Statement on Prescribing Shower Protection Pouches  Prescribing: requests from out of area  Private prescribing: patients presenting at an NHS GP practice following a private episode of care  Proton pump inhibitor (PPI): Primary Care Review Pathway  Psoriasis: LSCMMG Biologic and High Cost Drug Commissioning Pathway  Psoriasis: primary care guidance document  Psoriatic Arthritis: High Cost Drugs Commissioning Pathway  Recurrent UTI Prophylactic Antibiotic Pathway  Renal: Enhanced Supportive Kidney Care Guideline  Restless Legs Syndrome in Adults in Primary Care  Rheumatoid Arthritis: High Cost Drugs Commissioning Pathway  Riluzole: Patient Information  Rimegepant position statement  Scabies operational clinical pathway  Somatropin: Prescribing Information Leaflet  Stoma and continence Products Prescription Management guide  Tapentadol MR position statement  Tirzepatide for Type 2 Diabetes position statement  Tirzepatide: LSC ICB specialist weight management support in Lancashire and South Cumbria (June 2025)  Tirzepatide: Mounjaro® (tirzepatide) for managing overweight and obesity in primary care  Topiramate (Topamax) - Update for Primary Care: New Pregnancy Prevention Programme  Trans female gender dysphoria: Prescribing information sheet  Trans male gender dysphoria: Prescribing information sheet  Trans-Anal Irrigation Devices position statement  Vitamin D position statement v3.3